Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Child mortality from sickle cell disease in Nigeria: a model-estimated, population-level analysis of data from the 2018 Demographic and Health Survey
Obiageli Nnodu, Assaf P. Oron, Alayo Sopekan, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 10, pp. e723-e731
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
Azalea M Thomson, Theresa A. McHugh, Assaf P. Oron, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e585-e599
Open Access | Times Cited: 283
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
Frédéric B. Piel, David C. Rees, Michael R. DeBaun, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e633-e686
Open Access | Times Cited: 71
Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study
Brigitte Ranque, Robert Kitenge, Dado Doucoure Ndiaye, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 3, pp. e208-e216
Closed Access | Times Cited: 61
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease
Marta Ferraresi, Daniele Lello Panzieri, Simona Leoni, et al.
European Journal of Pediatrics (2023) Vol. 182, Iss. 6, pp. 2509-2519
Open Access | Times Cited: 17
The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology
Nancy Green, Andrew Zapfel, Obiageli Nnodu, et al.
Blood Advances (2022) Vol. 6, Iss. 24, pp. 6187-6197
Open Access | Times Cited: 25
The future of sickle cell disease therapeutics rests in genomics
Ambroise Wonkam
Disease Models & Mechanisms (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 16
Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines
Thomas V. Adamkiewicz, Marianne E. Yee, Stepy Thomas, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6751-6761
Open Access | Times Cited: 14
The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria
Oyesola Ojewunmi, Titilope A. Adeyemo, Ajoke Idayat Oyetunji, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 10, pp. 919-929
Open Access | Times Cited: 5
Unveiling mortality risk factors in paediatric sickle cell disease patients during acute crises in the Democratic Republic of the Congo
Paul Muteb Boma, Stéphanie Luntadila Ngimbi, Junior Makiese Kindundu, et al.
Blood Cells Molecules and Diseases (2024) Vol. 105, pp. 102828-102828
Closed Access | Times Cited: 4
Perceptions and preferences for genetic testing for sickle cell disease or trait: a qualitative study in Cameroon, Ghana and Tanzania
Nchangwi Syntia Munung, Karen Kengne Kamga, Marsha Treadwell, et al.
European Journal of Human Genetics (2024) Vol. 32, Iss. 10, pp. 1307-1313
Open Access | Times Cited: 4
Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study
Paul Bangirana, Amelia K. Boehme, Annet Birabwa, et al.
Frontiers in Stroke (2024) Vol. 3
Open Access | Times Cited: 4
The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis
George A. Morgan, Emily Back, Martin Besser, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Awareness, attitude, and acceptance of newborn screening for sickle cell disease among health workers and caregivers at primary healthcare centers in Gwagwalada Area Council, Federal Capital Territory, Abuja, Nigeria
Ivys Fernandez-Pastrañ a, Chisomaga Ifeanyi Oparaugo, Grace Doyin Ajetomobi, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
An implementation trial to mAnage siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE): Study protocol
Emmanuel Peprah, Joyce Gyamfi, John Pateña, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0311900-e0311900
Open Access
Genetic Modifiers in Sickle Cell Disease Leg Ulcers: Unveiling the Pathways associated with the development and, or progression of Leg Ulcers - A Scoping Review Protocol.
Livingstone Gayus Dogara, Sani Awwalu, Doyinsade Awodele
PubMed (2025) Vol. 65, Iss. 6, pp. 844-850
Closed Access
Application of Machine Learning Models in Predicting Malaria Prevalence in Nigeria: An Analysis of the 2015-2020 Demographic and Health Surveys
Thecla Okeahunwa Ayoka, Charles O. Nnadi
Research Square (Research Square) (2025)
Closed Access
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling
Daniel C. De Souza, Nicolas Hebert, Erica B. Esrick, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
The Changing Landscape of Opportunity for Cure of Severe Hemoglobinopathies in Middle-Income Regions
Lawrence Faulkner
Thalassemia Reports (2025) Vol. 15, Iss. 1, pp. 3-3
Open Access
Strategies to increase access to basic sickle cell disease care in low- and middle-income countries
Meghna Dua, Halima Bello‐Manga, Yvonne Carroll, et al.
Expert Review of Hematology (2022) Vol. 15, Iss. 4, pp. 333-344
Open Access | Times Cited: 13
Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019
Jean Gaschignard, Bérengère Koehl, David C. Rees, et al.
PEDIATRICS (2023) Vol. 152, Iss. 4
Closed Access | Times Cited: 7
Priorities for sickle cell disease global research and implementation
Ambroise Wonkam, Nchangwi Syntia Munung, Aldiouma Guindo, et al.
The Lancet (2024) Vol. 404, Iss. 10465, pp. 1790-1792
Closed Access | Times Cited: 2
Looking ahead: ethical and social challenges of somatic gene therapy for sickle cell disease in Africa
Nchangwi Syntia Munung, Obiageli Nnodu, Patrick Ohiani Moru, et al.
Gene Therapy (2023) Vol. 31, Iss. 5-6, pp. 202-208
Open Access | Times Cited: 6
Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria
Reuben Chianumba, Akinyemi O D Ofakunrin, Jack Morrice, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 10
Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests
Halimat Shadia Olaniyan, Christine Briscoe, Margarida Muhongo, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5860-5867
Open Access | Times Cited: 5
Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders
Hezekiah Isa, Emmanuel Okocha, Samuel Ademola Adegoke, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top